Swiss Stocks Extend Gains; Ypsomed Jumps on FY26 Results
The Swiss Market Index continued its winning streak on Wednesday, closing 0.26% higher, as earnings updates from companies continued to pour in.Ypsomed Holding (YPSN.SW) climbed 9.33% at close after reporting a surge in net profit for the year ended March 31, 2026, to 221.9 million francs from 87.5 million francs, while net sales from goods and services fell. Looking ahead, the injection and infusion systems maker expects 12% to 15% revenue growth in fiscal 2027, and 900 million francs to 1.1 billion francs in total revenue in the medium term.Meanwhile, EFG International (EFGN.SW) gained 0.69% as the private bank's net profit for the four months to April 30 clocked in at more than 130 million francs, compared with around 130 million francs a year ago.AlphaValue/Baader Europe maintained its positive view on Aevis Victoria (AEVS.SW) following the investment company's first-quarter results. The stock is rated buy, with a price target of 17.8 francs."Ahead of its Capital Market Day scheduled for today, AEVIS delivered a buoyant Q1 performance, highlighted by a remarkable profitability rebound at Swiss Medical Network and steady operational improvements at Infracore, which is actively preparing to go public," the research firm said. Aevis Victoria was down 0.75%.Elsewhere and in geopolitical news, Iran warned that the Middle East war would "spread far beyond the region" if the US and Israel resumed their attacks on the country following US President Donald Trump's threats.On the economic front, analysts are anticipating the release of the country's industrial production data for the first quarter on Thursday. The consensus estimate is a 0.5% rise, compared with the previously reported 0.7% decline.
